ADVERTISEMENT
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Related topics
PRESS RELEASE: Paid content from NewMediaWire
Press release content from NewMediaWire. The AP news staff was not involved in its creation.

EXICURE SHAREHOLDER NOTICE

November 25, 2021 GMT
Faruqi & Faruqi LLP
Faruqi & Faruqi LLP
Faruqi & Faruqi LLP

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 InExicure To Contact Him Directly To Discuss Their Options

NEW YORK - (NewMediaWire ) - November 24, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR).

If you suffered losses exceeding $50,000 investing in Exicure stock or options and would like to discuss your legal rights , call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/XCUR.

There is no cost or obligation to you. 

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

ADVERTISEMENT

On November 15, 2021, Exicure filed a Form 12b-25 with the SEC stating that it could not timely file its quarterly report for the period ended September 30, 2021. It explained that the Company was investigating “a claim made by a former Company senior researcher regarding alleged improprieties that researcher claims to have committed with respect to the Company’s XCUR-FXN preclinical program for the treatment of Friedreich’s ataxia.”

On this news, Exicure’s stock declined nearly 29% during intraday trading on November 16, 2021, thereby injuring investors.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

View the original release on www.newmediawire.com